http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0792178-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0df250cb6f03aa852ae5d4e8225e45dc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0444
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-044
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
filingDate 1995-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06df90dccd1c9822448d86af79fd12d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9996cfddbaf3b019edc599c0da0c9f79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea668e053e936a9073fa5359b41746a1
publicationDate 1997-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0792178-A1
titleOfInvention Ionophoretic device for transdermal administration of medicaments, and disposable assembly forming part of such device
abstract PCT No. PCT/FR95/01509 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Nov. 16, 1995 PCT Pub. No. WO96/14896 PCT Pub. Date May 23, 1996The device comprises a reservoir (3) containing an active principle in ionized form, first (1) and second (2) electrodes in contact with a face of the reservoir (3) and the skin (6) of the patient, respectively, the other face of the reservoir being applied to the skin (6) of the patient and means (5) for circulating selectively an electric current between said electrodes in order to help the passage of a flow of active principle under the patient's skin. The device further comprises a) a control grid (11) arranged on the face of the reservoir (3) which is intended to be applied to the skin (6) of the patient and b) control means (10), (9), (13) for cutting off the assistance current during a predetermined period of time and to circulate a reverse current between the grid (11) and the first electrode (1) which is intended to cancel substantially the passive flow of ions of the active principle which would otherwise pass under the patient's skin.
priorityDate 1994-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66583097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405446

Total number of triples: 27.